Manzhou Wang
No.1 East Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TACE combined with DynaCT-guided MWA in the treatment of high-risk location liver cancers with ≤5 cm tumor size.
Journal: Frontiers in oncology
Published: December 27, 2025
COLEC10 and COLEC11 are new serum biomarkers of chronic liver disease.
Journal: European journal of medical research
Published: October 29, 2025
Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non-Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial.
Journal: Journal of vascular and interventional radiology : JVIR
Published: August 14, 2025
Pioglitazone, a peroxisome proliferator‑activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species.
Journal: Oncology letters
Published: August 31, 2023
The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 10, 2022
Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling.
Journal: Journal of hepatocellular carcinoma
Published: August 30, 2022
Covalent organic polymer induces apoptosis of liver cancer cells via photodynamic and photothermal effects.
Journal: Frontiers in oncology
Published: July 05, 2022
Liposome quercetin enhances the ablation effects of microwave ablation in treating the rabbit VX2 liver tumor model.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: January 10, 2022
Drug-eluting bead transarterial chemoembolization followed by apatinib is effective and safe in treating hepatocellular carcinoma patients with BCLC stage C.
Journal: Clinics and research in hepatology and gastroenterology
Published: November 17, 2021
PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma.
PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma.
Journal: Cell death discovery
Published: June 30, 2021
Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization.
Journal: OncoTargets and therapy
Published: December 15, 2020
Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
Journal: Cell cycle (Georgetown, Tex.)
Published: December 07, 2020
Last Updated: 09/26/2026